Digital Health & E-Pharmacy: Reimagining Access, Trust & Care

Ashish Vig, CEO, Cipla Digital Health & Leader (Ecommerce, Modern Trade, Organized Retail Pharmacies)

 Ashish Vig, CEO, Cipla Digital Health

In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Ashish Vig, CEO, Cipla Digital Health & Leader (Ecommerce, Modern Trade, Organized Retail Pharmacies), discusses how digital health platforms are transforming India’s healthcare through improved access, AI-driven efficiency, and proactive care. He emphasizes the role of e-pharmacies in ensuring compliance, building trust, strengthening supply chains, and enabling a connected, patient-centric healthcare ecosystem.

Ashish Vig is a seasoned business leader with 17 years of experience in digital health, e-commerce, and business strategy. He specializes in building scalable businesses, driving monetization, and leading sales and distribution, with strong expertise in innovation, partnerships, and market expansion.

As digital health platforms rapidly grow in India, transforming patient access, how do you see this shift impacting healthcare delivery and patient outcomes?

The rapid growth of digital health platforms in India is fundamentally reshaping healthcare from a reactive system to a more proactive and accessible one. We are seeing a clear shift where geography is no longer a constraint. Patients in Tier 2 and Tier 3 cities now have access to qualified doctors, diagnostics, and medicines in ways that were previously unimaginable.

More importantly, digital platforms are improving continuity of care. With integrated patient records, e- prescriptions, and follow ups, outcomes are becoming more consistent and measurable. The real impact, however, lies in early intervention. Patients are engaging sooner, which reduces disease progression and overall healthcare costs.

In essence, digital health is not just improving access. It is democratizing quality healthcare while driving better clinical outcomes at scale.

Also Read: Pharmaceutical Procurement Strategies: How to Optimize Costs

With AI and machine learning transforming healthcare and improving diagnosis accuracy, how do you foresee these technologies enhancing digital health efficiency and overcoming adoption challenges?

AI and machine learning are becoming central to how we think about efficiency and accuracy in healthcare. From improving diagnostic precision to enabling personalized treatment pathways, these technologies are already delivering tangible value. AI is no longer artificial; it’s Augmented Intelligence.

For digital health platforms, AI helps streamline operations, whether it is demand forecasting, fraud detection, or optimizing supply chains. On the patient side, AI-driven tools such as symptom checkers and adherence reminders are enhancing engagement and outcomes.

That said, adoption challenges remain, particularly around trust, explainability, and regulatory clarity. To overcome this, we need to focus on transparent AI models, robust clinical validation, and strong collaboration with regulators. Ultimately, technology must augment not replace the clinician, and that is how we build confidence in the ecosystem.

Digital health is transforming India’s healthcare from reactive to proactive, breaking geographic barriers and enabling early intervention, consistent care, and improved outcomes at scale.

As telemedicine adoption accelerates across India and regulatory challenges remain, what steps can e-pharmacies take to navigate these hurdles and ensure compliance in this evolving landscape?

The regulatory landscape in India is evolving, and rightly so, given the sensitivity of healthcare. For e- pharmacies, the priority must be to stay ahead of compliance rather than react to it. This means building systems that ensure prescription validation, traceability of medicines, and adherence to data privacy norms. We also need strong partnerships with licensed pharmacies and healthcare providers to ensure accountability across the value chain.

Equally important is engaging constructively with policymakers. As an industry, we must contribute to shaping frameworks that balance innovation with patient safety. Those who invest early in compliance infrastructure will not only mitigate risk but also build long term credibility.

In the e-pharmacy sector, trust and data security are increasingly crucial as patient concerns grow. What steps can platforms take to enhance protection and foster lasting relationships?

Trust is the currency of digital healthcare. Without it, scale is meaningless. Patients are sharing highly sensitive information, so platforms must adopt a privacy first approach. End to end encryption, secure data storage, and strict access controls are non-negotiable. Beyond technology, transparency plays a big role. Patients should clearly understand how their data is used and protected. Another dimension of trust is authenticity. Ensuring that medicines are genuine, sourced from verified channels, and delivered with integrity is critical. Combining this with responsive customer support and pharmacist access creates a more human experience.

In the long run, trust is built not just through compliance, but through consistently doing the right thing for the patient

Given recent supply chain disruptions affecting many sectors, how can e-pharmacies innovate logistics and stock management to meet growing demand while ensuring timely medication delivery?

Supply chain resilience has become a strategic priority for e-pharmacies. The key is moving from linear supply chains to intelligent, technology enabled networks. We are increasingly leveraging data analytics for demand forecasting, enabling better inventory planning and reducing stockouts.

Distributed warehousing and micro fulfillment centers are helping us get closer to the customer, improving delivery timelines. Technology also plays a role in real-time tracking and cold chain management for sensitive medicines. At the same time, partnerships with local pharmacies and logistics providers create a hybrid model that is both scalable and resilient.

Ultimately, the goal is to ensure that critical medications reach patients reliably, because in healthcare, delays can have serious consequences.

Also Read: Advanced Formulation Technologies Streamlining Global Pharma Innovation

Looking ahead, as digital health holds immense potential to revolutionize patient care, what innovations do you foresee in this space, and how can e-pharmacies contribute?

Looking ahead, digital health in India is poised for a significant leap. We will see deeper integration across the ecosystem. Consultations, diagnostics, pharmacies, and insurance will come together to create a seamless patient journey.

Personalization will be a major trend, driven by data and AI. Tailored treatment plans, predictive healthcare, and preventive care models will become more mainstream. Wearables and remote monitoring will further shift care from hospitals to homes. E-pharmacies will play a critical role in this ecosystem, not just as medicine delivery platforms, but as comprehensive health partners. From chronic care management to medication adherence programs and health analytics, the scope is expanding rapidly.

In many ways, we are moving toward a model where healthcare is continuous, connected, and patient-centric, and e-pharmacies will be at the heart of enabling that transformation.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles


© 2026 India Pharma Outlook. All Rights Reserved.